vaccine_rfp_final~1.pdf

State of Minnesota

MMCAP INFUSE

OFFICE OF STATE PROCUREMENT

Request for Proposals (“RFP”) for

Distribution of Vaccines and Vaccine-related Products

Minnesota’s Commitment to Diversity and Inclusion

The State of Minnesota is committed to diversity and inclusion in its public procurement process. The goal is to ensure that those providing goods and services to the State are representative of our Minnesota communities and include businesses owned by minorities, women, veterans, and those with substantial physical disabilities. Creating broader opportunities for historically under-represented groups provides for additional options and greater competition in the marketplace, creates stronger relationships and engagement within our communities, and fosters economic development and equality.

To further this commitment, the Department of Administration operates a program for Minnesota-based small businesses owned by minorities, women, veterans, and those with substantial physical disabilities. For additional information on this program, or to determine eligibility, please call 651-296-2600 or go to www.mn.gov/admin/oep.

http://www.mn.gov/admin/oep

Table of Contents

SECTION 1 – INSTRUCTIONS TO RESPONDERS .......................................................................... 3-4

SECTION 2 – RFP PROJECT INFORMATION ................................................................................ 5-7

SECTION 3 – NARRATIVE RESPONSE AND PROPOSED SCOPE OF WORK AND SERVICES ....... …. 8-16

SECTION 4 – COST PROPOSAL

SECTION 5 – RESPONDER CERTIFICATIONS

EXHIBIT A – GENERAL REQUIREMENTS ..................................................................................... 19-21

EXHIBIT B – AGREEMENT TEMPLATE

EXHIBIT C – CERTIFICATION REGARDING LOBBYING

EXHIBIT D – WORKFORCE AND EQUAL PAY DECLARATION FORM

EXHIBIT E –VETERAN OWNED PREFERENCE

EXHIBIT F –MMCAP INFUSE -CONTRACTED VACCINE SUPPLIERS ............................................. 26-27

EXHIBIT G –PROPOSED DISTRIBUTION CENTERS

EXHIBIT H – FORMS AND APPLICATIONS

EXHIBIT I – SAMPLE INVOICE

EXHIBIT J – SAMPLE CREDIT MEMO

EXHIBIT K - REFERENCES SHEET…………………………………………………………………………………………….. 32

SECTION 1 – INSTRUCTIONS TO RESPONDERS

RFP Timeline:

RFP Release Date March 7, 2024 Cutoff Date for Questions April 2, 2024, 2 p.m. Central Time Final Answers to Questions Posted April 9, 2024 Proposal Due Date April 30, 2024, 2 p.m. Central Time Contract Effective Date No later than September 1, 2024

Steps for Completing Your Response

Follow the steps below to complete your response to this RFP:

Step 1: Read the solicitation document and ask questions, if any Step 2: Compose your response

Step 3: Sign and submit your response

Incomplete Responses

A proposal must be submitted along with any required additional documents.

Incomplete proposals that materially deviate from the required format and content may be rejected.

STEP 1 – READ THE SOLICITATION DOCUMENT & ASK QUESTIONS, IF ANY

How to Ask Questions

Via email, at the email address below. Include RFP Response Distribution of Vaccines and Vaccine-related Products in the subject line.

MMCAP_Infuse.RFP@state.mn.us

Questions will be responded to, via an addendum to this RFP, in batches as they arrive and will not be attributed to the asking entity. Similar questions may be combined into a single answer.

STEP 2 – WRITE YOUR RESPONSE

Request for Proposals (RFP)

In Section 3, insert your response to the questions in the order they are asked or provide content, as requested.

In Section 4, compose your cost proposal considering the questions given.

STEP 3 – SIGN & SUBMIT YOUR RESPONSE

Documents making up a complete proposal

Narrative Response and Proposed Scope of Work and Services (SOW) (submitted in Microsoft Word and PDF) Section 3

Cost Proposal (in a separate document from the narrative response) (submitted in Microsoft Excel) Section 4

Agreement Template (submitted in Microsoft Word unlocked, unrestricted for editing with track changes and separate from RFP Response) Exhibit B

Certification Regarding Lobbying (submitted in PDF) Exhibit C Workforce and Equal Pay Declaration Form (submitted in PDF) Exhibit D If applicable, Exhibit E: Veteran Owned Preference (submit in PDF) Required business applications, forms, and requested information to do business with Responder in Exhibits F - K Signature in Section 5

Where to Send Your Response

Email your response to: MMCAP_Infuse.RFP@state.mn.us In the Subject line of your email response, place Responder’s company name followed by RFP Response Distribution of Vaccines and Vaccine-related Products.

Response Submission Deadline

Responses must be received by the deadline given in this RFP, as indicated by the email timestamp. Late proposals will not be considered. All costs incurred in responding to this RFP will be borne by the responder.

By submitting this response, your firm is making a legal, binding offer for a contract to provide services to the State of Minnesota.

SECTION 2 – RFP PROJECT INFORMATION

A. Description of Project

MMCAP Infuse is a governmental group purchasing organization (GPO) serving thousands of state and local government facilities across the United States. MMCAP Infuse is operated by the State of Minnesota Department of Administration’s Office of State Procurement and is governed by Minnesota laws and procurement policies.

MMCAP Infuse members are state agencies and political subdivisions generally falling under the following classes of trade: correctional facilities, psychiatric treatment facilities, student health services, public health services, long term care facilities, and public hospitals and clinics. For more information on MMCAP Infuse and its Members or membership, visit https://infuse-mn.gov/.

MMCAP Infuse is issuing this Request for Proposals (RFP) to establish contract(s) with qualified distributors that will provide vaccine and vaccine-related distribution services to Members. MMCAP Infuse currently has three contracted vendors for these services which are approaching the end of their contract terms and is looking to establish new contracts. MMCAP Infuse is soliciting for vendors that will firstly distribute vaccines of all types. This solicitation also aims to include distribution of vaccine-related products such as toxoids and diagnostic agents commonly used in an immunizing setting, monoclonal antibodies used for the prevention of disease. MMCAP Infuse will consider unique, value-added, vaccine-related services as part of this RFP such as mechanisms of vaccine storage, ordering, or replenishment. Certain products including coagulation products, hyperimmune globulins, and immune globulins may also be considered under this RFP but not as a standalone offering. Upon contract award, Members may select from the list of MMCAP Infuse awarded contracted vendors to purchase these products. MMCAP Infuse has pharmaceutical manufacturer and generalized pharmaceutical wholesaler contracts in place and such products and services are not solicited via this RFP. This RFP is not for vaccine manufacturer responses.

Usage data Usage data provided is not an indication or guarantee of business and is provided for reference of members’ past utilization of vaccines.

Approximate number of Members currently purchasing vaccine and related products via distributors

Influenza Other Vaccine 570 1500

Approximate number of doses of influenza vaccines purchased via vaccine distributors only

Manufacturer 2018-2019 Season 2021-2022 Season

2022-2023 Season

AstraZeneca 154,000 6,400 15,000

GSK 130,000 130,000 58,000

Sanofi Pasteur 175,000 7,000 20,000 Seqirus 470,000 165,000 214,000

Total doses 929,000 308,000 307,000

Approximate number of packages of non-influenza vaccine and vaccine products utilized through MMCAP Infuse distributors from Jan 1 2023 – Dec 31 2023 is attached separately, please download document on the OSP website:

https://osp.admin.mn.gov/GS-auto labeled as Addendum 1.

https://infuse-mn.gov/

B. Sample Business Functions

For a detailed view into the Scope of Work (SOW), see Section 3 of this RFP below. The following is a brief list of many of the expected business functions of Responders:

• Providing customer service, including account management for both Members and MMCAP Infuse;

• Ensuring adequate supply through inventory management, including stocking vaccines, managing stock outages and communicating manufacturer backorders;

• Managing MMCAP Infuse contract vaccine processes, including price loading, price accuracy, product additions and deletions and product expiration dates;

• Supplying ordering systems for order placement, and providing training to Members;

• Delivering products through routine delivery, drop-shipments, special requests, and emergency orders;

• Complying with the Drug Supply Chain Security Act (DSCSA, under Title II of the Drug Quality and Security

Act H.R. 3204);

• Invoicing Members accurately, including submitting credits and rebills, chargebacks, product returns,

• Informing Members about reverse distribution and recalls;

• Applying accurate payment terms;

• Implementing awarded offerings;

• Planning for business continuity through interruption;

• Distributing Shareback credits (future potential);

• Educating Members on any applied fees or available price structures;

• Reporting Member sales, prebooking of future seasons, and ad hoc reporting;

• Providing any other value-added services Responder provides to other customers.

In addition to the tasks or activities set forth above, Responders are encouraged to propose additional products/services that may improve the results of this project. The proposed additional products/services, along with their associated cost, must be separated from the RFP-required proposal items on the Responder’s cost proposal.

C. Minimum Qualifications Required (Pass / Fail criteria)

1. Proposals must be received on or before the due date and time specified in this RFP (Pass/Fail)

2. Responder must have returned a completed Narrative Response and Proposed Scope of Work and Services

(Section 3) and completed Exhibits F through K (Pass/Fail)

3. Authorized Wholesaler/ Distributor relationship with at least ten (10) of the listed suppliers in Exhibit F

(Pass/Fail)

4. Responder must demonstrate chargeback capabilities to the MMCAP Infuse contract price with at least eight

(8) of suppliers listed in Exhibit F (Pass/Fail)

5. Responder must have current and verifiable NABP Drug Distributor Accreditation (Pass/Fail)

6. Responder must be a licensed Authorized Trading Partner under Title II of the Drug Quality and Security Act, DSCSA (Pass/Fail)

7. Responders must show proof of being licensed to distribute pharmaceuticals/vaccines in at least five (5) states

(Pass/Fail)

D. Desired Experience / Skills

Responders with a strong understanding of the pharmaceutical distribution industry with a focus in vaccines are desired. A deep understanding of the needs and challenges of government facilities procuring vaccines will assist in the success of resulting contract(s).

E. Response Evaluation

Responses will first be reviewed to confirm compliance with the minimum qualifications identified above.

Responses that meet all the minimum qualifications will be further evaluated in accordance with the following from the responses in the Scope of Work and Services. Costs will be separately evaluated.

Factors Percentage Experience & Background, Regulatory Requirements 10% Inventory, Product and Pricing Management 10% Customer Service, Ordering, Invoicing, Shipment, Delivery, Returns 30% Reporting, Data Transfer, and Cybersecurity 10% Cost 40%

Preference Points (if applicable)

Preference points are described under the State’s General Requirements and will be applied to the total score after points have been awarded.

• 12% Minnesota Certified Targeted Group/Economically Disadvantaged Preference

• 12% Veteran-owned Preference

• Minnesota Resident Vendor Preference

MMCAP Infuse reserves the rights to reject any and all proposals, to close or extend this RFP by addendum, or reissue the RFP. Responses will be evaluated by a team of MMCAP Infuse Staff and/or Members. Evaluators will read, review, and evaluate all proposals that have passed all the minimum qualifications. MMCAP Infuse also reserves the right to request a demonstration of Responder’s capabilities and/or ordering systems via in-person meetings, webinar, or other such mechanism.

SECTION 3 – NARRATIVE RESPONSE AND PROPOSED SCOPE OF WORK AND SERVICES

(Spans pages 8-16 and includes 3 subsections: A,B, and C)

A. MMCAP Infuse Vendor Information and Response Form

i. General Information

Company Information

Complete legal name:

Complete mailing address:

Web site address:

Federal Employer Identification Number (FEIN):

Company Contacts Primary Contact Name

Title

Telephone

E-mail address

Alternative Contact Name

Title

Telephone

E-mail address

Administrative Fee Contact Name

Title

Telephone

E-mail address

Data and Reporting Contact

Title

Telephone

E-mail address

General Customer Service

Telephone number

E-mail address

ii. Compliance with minimum qualification. Proposals that have not responded to each Pass/Fail question may not be considered further.

Does Responder comply with each term? Respond Yes or No. Each criterion is Pass/Fail.

Yes No Term

Proposals must be received on or before the due date and time specified in this RFP

Responder must have returned a completed Narrative Response and Proposed Scope of Work and Services (Section 3) and completed Exhibits F through K

Authorized Wholesaler/Distributor relationship with at least ten (10) of the listed suppliers in Exhibit F

Responder must demonstrate chargeback capabilities to the MMCAP Infuse contract price with at least eight (8) of the suppliers listed in Exhibit F

Responder must have current and verifiable NABP Drug Distributor Accreditation

Responder must be a licensed Authorized Trading Partner under Title II of the Drug Quality and Security Act, DSCSA

Responder must show proof of being licensed to distribute pharmaceuticals/vaccines in at least five (5) states

B. Scope of Work and Services Any links provided in the narrative response will not be considered. All documents referenced in your response must be submitted with the proposal to be considered.

Experience and Background

1. Will Responder be proposing regional (five or more states) or national (all fifty states) distribution coverage?

a. If proposing regional distribution, provide a complete list of the states serviced.

2. List the addresses of the distribution center locations in Exhibit G. How do the locations of Responder’s distribution centers promote quality and continuity of customer service?

3. From a general overview, describe how Responder will provide for the distribution of routine vaccines, seasonal vaccines, and other vaccines and vaccine-related products for Members. Include all the distribution services you offer, in detail.

4. Include a summary of information regarding the financial status and current economic conditions of Responder.

5. How long has Responder been in the pharmaceutical and vaccine distribution business? What other products does Responder distribute? What percent of Responder’s current business does vaccine distribution represent?

6. How quickly can vaccine distribution services be provided from the Responder once a fully executed contract is in place?

7. What level of MMCAP Infuse participation will be required in the implementation and ongoing management of a resulting contract? What other assistance does Responder expect to be provided by MMCAP Infuse?

8. What are Responder’s measures of success? Explain any volume or service level targets Responder maintains.

9. Are there any limitations or exclusions Members may be subject to when using your services?

10. What are the names of Responder’s closest competitors and what differentiates Responder from these vendors?

11. Complete and submit three copies of Exhibit K with your response. List names, addresses, telephone numbers, and e-mail addresses of three references to which Responder has supplied vaccines or vaccine-related products to in the past three years. Include how these references relate to institutions and corporations of similar scope as Members. One reference must be a government entity. MMCAP Infuse reserves the right to contact any or all references at any point during the evaluation.

Regulatory Requirements

Responder must be able to meet all regulatory requirements to provide vaccine distribution including but not limited to the Federal Drug Administration (FDA), Drug Enforcement Agency (DEA), and all applicable state regulations. Responder must ensure Members will receive the correct vaccines ordered per specifications set forth by the facility and applicable laws.

12. Describe how Responder currently and continuously will comply with FDA, DEA, state, and other national regulations.

13. Describe how regulatory changes will be communicated to MMCAP Infuse and Members to ensure all parties are kept informed of changes which may affect them.

14. How does Responder maintain an environment for the storage of vaccines that adheres to all regulations and manufacturer specifications?

15. Have you received a citation or warning letter from the FDA in the last 3 years? If yes, include the unredacted information regarding the findings and how Responder remedied the situation.

16. Explain Responder’s DSCSA compliance measures. How is this integrated into your processes? How does Responder provide DSCSA purchasing information to customers? What are your capabilities to export EPCIS data to other data storage vendors?

17. How will Responder ensure and validate that every facility has a GLN as required for DSCSA compliance? What will happen if a facility does not have a GLN? How will Responder address a facility that may have duplicate GLNs?

18. How is DSCSA data securely stored? Is this data storage capacity outsourced, and if yes, who is your outsourced vendor for data storage? Is the DSCSA data stored in the USA?

19. Has Responder ever been found to have distributed fraudulent product? What steps were taken to avoid recurrence?

20. How long does Responder store DSCSA purchasing information for customers? Are there any purchasing requirements from customers for Responder to retrieve their purchasing information for DSCSA compliance purposes? Explain how this data will be readily accessible to Members within the timeframe required by law.

Inventory, Product and Pricing Management

21. Describe how Responder will ensure sufficient stock MMCAP Infuse contract vaccines for Members. What does

Responder require from MMCAP Infuse or its Members to ensure sufficient stocking?

22. On average, how many days’ inventory does Responder keep available at each of its distribution centers? How quickly can product be moved from one distribution center to another to meet a Member’s demand? Under what circumstances would product be shipped directly to the Member from a different distribution center?

23. Describe the steps in Responder’s prebooking process for influenza vaccine.

24. What guarantees does a Member receive for prebooking their order? Under what circumstances are prebooked orders cancelled by Responder? What remedies are provided to a Member if a prebooked order is cancelled by Responder?

25. Describe how Responder manages contracts that require a GPO Declaration (DEC) form for Members to be eligible for contract pricing?

26. Describe the chargeback process that Responder has in place with the manufacturers. How will Responder honor MMCAP Infuse contract pricing with Manufacturers?

27. How does the Responder handle contract price loading for multiple tiers of pricing, such as commitment programs whereby manufacturers will specify which Member is eligible for each contracted tier price?

28. MMCAP Infuse will provide a weekly listing of contracted products and pricing. How will Responder use this list to ensure MMCAP Infuse contracted products are stocked and priced correctly?

29. What percentage of vaccine products does Responder receive contracts and pricing electronically from manufacturers via Electronic Data Interchange (EDI)?

30. What are Responder’s current quality controls or auditing processes that ensure MMCAP Infuse contract pricing would be achieved for Members?

31. What is Responder’s process and communication strategy if Responder receives a chargeback denial for a Member?

32. How and when does Responder communicate with Members related to stock outages, backorders, allocations?

33. What would Responder need from MMCAP Infuse to meet the goals of the resulting contract (e.g., resources, Membership listing, etc.)?

Customer Service

34. Describe and demonstrate Responder’s customer service operation for responding to Members’ needs.

35. Where is Responder’s customer service center(s) located? What are the hours of operation? How does this achieve quality customer service for customers in all U.S. time zones?

36. List Responder’s experience and that of the individuals that will be assigned to a resulting contract. How they will interact with MMCAP Infuse and Members utilizing the contract.

37. How does Responder address situations where a customer is a member of more than one GPO or buying group?

How does Responder attach that customer to a contract? Does Responder require customers to complete a GPO declaration form? How does Responder ensure that the person signing the form has the legally binding authority to do so?

38. Under what circumstances would Responder encourage or offer to open a second account for a customer for an alternative GPO, buying group, or alternative contract? How would such sales be reported?

39. What is Responder’s procedure for responding to MMCAP Infuse Membership inquiries during non-operational hours, including holidays?

40. How are Responder’s customer service representatives trained on specific aspects of a GPO contract?

41. Explain Responder’s dispute resolution process.

42. Describe Responder’s customer service operations related to GPOs.

Ordering

43. Enclose as Exhibit H, a copy of all applications, declaration forms, and/or customer account set up information that will be utilized in the creation of Member accounts with Responder.

44. Describe the process of account set up and attaching Members to contracted products for distribution. How will Responder ensure only Members are viewing and receiving MMCAP Infuse contract pricing?

45. Describe Responder’s ability to identify Member accounts that are not attached to MMCAP Infuse contracts or any contracts.

46. Describe how Members will order vaccines. List the methods of placing orders (e.g., email, online orders).

47. Can a view-only/non-ordering account be set-up for staff of MMCAP Infuse? If so, will this account show real-time inventory levels? Will it be mirroring a specific Member (with tiered pricing applied) or loaded with base pricing available to all Members?

48. When ordering online, how will Members know a product is on the MMCAP Infuse contract versus a non-contracted item?

49. Are there any order minimums?

50. How do customers receive confirmation of their orders?

51. List Responder’s process for emergency orders.

52. Explain Responder’s process for managing expired and short dated product.

Invoicing Members will be invoiced at the more advantageous price between the MMCAP Infuse contract price and the Responder's prices throughout the term of the contract.

53. Will Responder submit an invoice with each order?

54. Enclose a sample of Responder’s invoice as Exhibit I

55. Is this invoice customizable?

56. Will Responder’s invoices contain the following fields? Indicate yes / no in the table below.

Facility Name

Vendor-assigned account number

Invoice number

MMCAP Infuse Member's purchase order number

Invoice date

NDC (11 digit)

Product Name/Description

Packaging Type

Unit price

Quantity ordered

Quantity shipped

Extension (unit price multiplied by the quantity shipped)

Total invoice price

Bill to address

Ship to address

Shipment

All products will be packed in suitable containers for protection in shipment and in accordance with applicable manufacture specifications.

57. Describe processes related to picking correct products and give picking accuracy rate for Responders distribution center(s).

58. Describe all shipping options.

59. Will orders for multiple products be shipped together? Define this process.

60. How will the container with the packing slip be clearly identified?

61. Will all shipping containers have appropriate identification of storage requirements on the outside of the container (e.g., refrigerate upon arrival)?

62. How will lost in mail claims be addressed?

63. What designated carriers does Responder use to ship finished products to facilities? (e.g., USPS, UPS, FedEx, etc.)

64. Explain the custody process and how it is transferred. (e.g., FOB Destination). What insurance is provided standard to all customers via carrier delivery?

Delivery

65. What is Responder’s timeline from order to delivery to the Member? If certain products take longer to obtain than others, please list by individual vaccine.

66. How are deliveries accounted for? (e.g., carrier tracking numbers) Are signatures required for delivery?

67. List sites to which Responder can deliver to (e.g., pharmacy, loading dock, front desk, etc.). How do customers identify their preference to Responder?

Returns

68. Clearly articulate the Responder’s return policy. Does Responder utilize the manufacturer return policy or have more stringent return policies? Explain the impact of DSCSA.

69. How will Members return items to Responder that were sent to the Member in error?

70. How will damaged products delivered to the Members be managed?

71. How quickly can Responder replace damaged product received by the Members?

72. How will credits for returned products be handled?

73. Are credit memos clearly identified as such? Include a sample copy of a credit memo as Exhibit J

74. Describe the processes and methods used for alerting Members in the event of a recall of products. Include timelines, follow up procedure, and other means Responder utilizes for recalls.

75. How will DSCSA impact Responder’s ability to send recall notices to only verified purchasers? Will notices be sent to each ship-to location for which Responder has a sales history within the affected recall timeframe?

Reports and Data Transfer

76. What reporting elements are available to Members? Are these customizable? How will Members access the reports available to them? In what format (PDF, Excel) are these reports made available? How often are the reports data updated, e.g. real-time, next day, weekly, etc.? Are the reports available to Members searchable?

77. What reporting elements are available to the MMCAP Infuse at the organization level (as opposed to members)?

How can reports be accessed? Can reports be autogenerated and sent to MMCAP Infuse on a scheduled basis?

How often are the sales data updated, e.g. real-time, next day, weekly, monthly, etc.?

78. The reports to MMCAP Infuse will need to be searchable and sorted in various ways. Can this be achieved?

79. Monthly Sales Data Usage Report. Indicate in the last column in the table below whether Responder can submit the requested information to the MMCAP Infuse in a monthly report.

Excel Column Required Data Field Full Name for Sales Data Report

Yes/No

A MMCAP Infuse-assigned Member ID

B MMCAP Infuse Member Name

C Vendor Distribution Center Code

D Vendor-assigned Account Number for MMCAP Infuse Member (this should be the ship-to account number)

E Invoice Number

F Invoice Line Number

G Purchase Order Number

H Invoice date (MMDDYYYY)

I Buyer name or equivalent of buyer ID for person submitting the invoices (if available)

J Vendor's (distributor) SKU item number

K NDC of purchased Product as stored in First DataBank, Inc. (Required for pharmaceutical Products)

L Label Name/Product Description

M Unit Dose (Required for pharmaceutical Products)

N Pack Size

O Unit

P Case Size

Q Dose (Required for pharmaceutical Products)

R Strength (Required for pharmaceutical Products)

S Route (Required for pharmaceutical Products)

T Unit Price (99999.9999)

U Quantity Ordered (not Vendor repackaged or re-bundled quantity)(99999.9999)

V Quantity Shipped (not Vendor repackaged or re-bundled quantity)(99999.9999)

W Extension (unit price multiplied by the quantity shipped) EXTENDED PRICE (99999.9999)

X Type of transaction 1= MMCAP Infuse Contract Product sale, 2=Alternate Contract, 3=Non-contract Product Sale

Y Bill to Address 1

Z Bill to City

AA Bill to State (2 alpha postal code)

AB Bill to Zip (standard 5-4 format, no dash necessary)

AC Ship to Address 1

AD Ship to City

AE Ship to State (2 alpha postal code)

AF Ship to Zip (standard 5-4 format, no dash necessary)

AG Service Fee (99999.9999)

AH Vendor contract ID the chargeback was submitted against

AI Admin Fee

AJ Credit Indicator (C for credit)

AK

MMCAP Infuse Assigned Vendor Code (Codes will be assigned during the implementation period of the contract)

AL Manufacturer Name (MFG Name)

AM Class of Trade

AN 340B Purchase (not applicable)

AO Category

AP Manufacturer Part Number

AQ List Price

AR UNSPSC Code (XXXXXXXX)

AS UNSPSC Description

AT GLN

AU GTIN

AV Order Date (MMDDYYYY)

Cybersecurity

80. What has Responder done to address cybersecurity threats and vulnerabilities that may impact your business?

81. Does Responder maintain insurance coverage for cybersecurity/ransomware? At what coverage level?

82. Explain Responder’s use of safeguards such as encryption, antivirus and anti-malware programs. Describe

Responder’s process to contact customers via email or other electronic messaging. Identify whether Responder uses secure email or any procedures to authenticate customer instructions received via email or electronic messaging, to work against the possibility of customer impersonation.

Additional Service Offerings

83. List Additional Service Offerings not identified in this proposal that would benefit Members. MMCAP Infuse is looking to expand the scope of vaccine distribution; optional offers and pricing is encouraged. Pricing for any of these additional products and services must be outlined in the “Cost Proposal Sheet” under Additional Service Offerings Pricing.

C. Alterations or Additions to the State’s RFP Terms & Conditions

If you wish to take an exception to the State’s General Requirements (see Exhibit A), please indicate that below and attach any appropriate documentation. Only the template provided here will be accepted.

☐None ☐See attached document detailing proposed alterations and/or additions to the MMCAP Infuse terms.

SECTION 4 – COST PROPOSAL

Follow the instructions below when completing your cost proposal. Your cost proposal must be submitted in a separate file. No cost information should be provided in Section 3.

Responder must submit a cost proposal that details their proposed cost structure to Members. Below, is the requested information to be provided. Utilize additional documents or Excel format to provide innovative approaches to costs.

Consider what would benefit Members most and the MMCAP Infuse model of chargebacks to the MMCAP Infuse contract price with the manufacturers.

Cost Structure, Payment Terms and Fees (All answers to this section must be in a file separate from the rest of the response, Microsoft Excel format is preferred)

A. Describe Responder’s proposed cost structure for non-influenza vaccines and vaccine-related products.

B. Describe Responder’s proposed pricing structure related to influenza vaccine.

i. How will Responder ensure influenza vaccine is priced competitively?

C. List available payment terms and discounts for prompt payments. (e.g. 2%30day/Net 31, etc.)

i. Clearly define these payment terms.

D. Are overall volume tiered discounts available from Responder?

i. If yes, how will these tiers be established for all Members E. Describe the Responder’s policy for any service fee discounts.

F. How and what would constitute a change in a discount for Members?

G. Does Responder currently negotiate with individual customers for deeper discounts beyond GPO base pricing structures? Explain how this information is relayed to the GPO.

H. Are purchasing/credit cards payments acceptable?

i. If so, would additional fees be assessed? (list the actual fees in the cost proposal) I. Is Electronic Funds Transfer (EFT) available for payment of invoices?

J. Define Responder’s late payment policy and describe how vendor will engage in collection activities.

K. Cost reduction – Are there any other ways that Responder would consider pricing the services in this RFP to

Members?

L. Pricing for Additional Service Offerings, as applicable

SECTION 5 – RESPONDER CERTIFICATIONS

Responder must check each box to certify to the conditions required under this RFP. Please note that some certifications may require the submission of additional information. Sign below to finalize response.

A. Required ☐ I have read and am aware of the State’s General Requirements as attached as Exhibit A.

☐ I have COMPLETED and ATTACHED Exhibits C (Certification Regarding Lobbying), D (Workforce Certificate).

B. If Applicable ☐ I am a certified veteran-owned business, in accordance with Minn. Stat. § 16C.16, subd. 6a and § 16C.19 (d).

The eligibility criteria are available at www.mmd.admin.state.mn.us/pdf/VetPref.pdf. Please complete Exhibit E.

☐ I am a resident vendor, in accordance with 2013 Minn. Laws, Chapter 142, Article 3, Sec. 16. The eligibility criteria are available at www.mmd.admin.state.mn.us/pdf/ResidentVendorForm.pdf.

By signing here, I warrant that the information provided in this proposal is true, correct, and reliable for purposes of evaluation for potential contract award. The submission of inaccurate or misleading information may be grounds for disqualification from contract award and may subject me/my company to suspension or debarment proceedings, as well as other remedies available to the State, by law.

Signature Title Date http://www.mmd.admin.state.mn.us/pdf/VetPref.pdf http://www.mmd.admin.state.mn.us/pdf/ResidentVendorForm.pdf

EXHIBIT A

General Requirements

Conflicts of Interest

Responder must provide a list of all entities with which it has relationships that create, or appear to create, a conflict of interest with the work that is contemplated in this request for proposals. This includes any conflict of interests the Responder may have with a Member. The list should indicate the name of the entity, the relationship, and a discussion of the conflict.

Organizational Conflicts of Interest

To the best of Responder’s knowledge and belief, and except as otherwise disclosed, there are no relevant facts or circumstances which could give rise to organizational conflicts of interest. An organizational conflict of interest exists when, because of existing or planned activities or because of relationships with other persons, A. vendor is unable or potentially unable to render impartial assistance or advice to the State;

B. the vendor’s objectivity in performing the contract work is or might be otherwise impaired; or C. the vendor has an unfair competitive advantage.

If after award, an organizational conflict of interest is discovered, an immediate and full disclosure in writing must be made to the State’s Chief Procurement Officer which must include a description of the action which the contractor has taken or proposes to take to avoid or mitigate such conflicts. If an organization conflict of interest is determined to exist, the State may, at its discretion, cancel the contract. In the event the Contractor was aware of an organizational conflict of interest prior to the award of the contract and did not disclose the conflict to OSP, the State may terminate the contract for default. Organizational conflicts of interest terms apply to any subcontractors for this work.

Proposal Contents

The information provided is true, correct, and reliable for purposes of evaluation for potential contract award. The submission of inaccurate or misleading information may be grounds for disqualification from the award as well as subject the Responder to suspension or debarment proceedings as well as other remedies available by law.

Responses are Nonpublic during Evaluation Process

All materials submitted in response to this Solicitation will become property of the State. During the evaluation process, all information concerning the responses submitted will remain private or nonpublic and will not be disclosed to anyone whose official duties do not require such knowledge. Responses are private or nonpublic data until the completion of the evaluation process as defined by Minn. Stat. § 13.591. The completion of the evaluation process is defined as the State having completed negotiating a contract with the selected responder. The State will notify all responders in writing of the evaluation results.

The State will not consider the prices submitted by the Responder to be proprietary or trade secret materials.

Notwithstanding the above, if the State contracting party is part of the judicial branch, the release of data shall be in accordance with the Rules of Public Access to Records of the Judicial Branch promulgated by the Minnesota Supreme Court as the same may be amended from time to time.

Contingency Fees Prohibited

Pursuant to Minnesota Statutes Section 10A.06, no person may act as or employ a lobbyist for compensation that is dependent upon the result or outcome of any legislation or administrative action.

Administrative Fee. In consideration for the administrative support and other services provided by MMCAP Infuse, the Responder agrees to pay an Administrative Fee of three percent (3%) on all purchases of products and services.

Reimbursements

Reimbursement for travel and subsistence expenses actually and necessarily incurred by the contractor as a result of the contract will be in no greater amount than provided in the current "Commissioner’s Plan” promulgated by the commissioner of Minnesota Management and Budget and will not be made for travel and subsistence expenses incurred outside Minnesota unless contractor has received the State’s prior written approval for out of state travel.

Minnesota will be considered the home state for determining whether travel is out of state.

Targeted Group, Economically Disadvantaged Business, Veteran-Owned and Individual Preference.

Unless a greater preference is applicable and allowed by law, in accordance with Minn. Stat. § 16C.16, businesses that are eligible and certified by the State as targeted group (TG) businesses, economically disadvantaged (ED) businesses, and veteran-owned (VO) businesses will receive points equal to 12% percent of the total points available as preference.

For TG/ED/VO certification and eligibility information visit the Office of Equity in Procurement website at https://mn.gov/admin/business/vendor-info/oep/ or call the Division’s Helpline at 651.296.2600.

Workforce Certification

For all contracts estimated to be in excess of $100,000, responders are required to complete the attached Affirmative Action Data page and return it with the response. As required by Minnesota Rule 5000.3600, “It is hereby agreed between the parties that Minnesota Statute § 363A.36 and Minnesota Rule 5000.3400 - 5000.3600 are incorporated into any contract between these parties based upon this specification or any modification of it. A copy of Minnesota Statute § 363A.36 and Minnesota Rule 5000.3400 - 5000.3600 are available upon request from the contracting agency.”

Non-Collusion Certification.

A. The Proposal has been arrived at by the Responder independently and has been submitted without collusion and without any agreement, understanding or planned common course of action with any other vendor designed to limit fair or open competition; and

B. The contents of the Response have not been communicated by the Responder or its employees or agents to any person not an employee or agent of the Responder and will not be communicated to any other individual prior to the due date and time of this Solicitation. Any evidence of collusion among Responders in any form designed to defeat competitive responses will be reported to MMCAP Infuse for investigation and appropriate action.

Certification Regarding Lobbying

For State of Minnesota Contracts and Grants over $100,000, the undersigned certifies, to the best of his or her knowledge and belief that:

https://mn.gov/admin/business/vendor-info/oep/

A. No Federal appropriated funds have been paid or will be paid, by or on behalf of the undersigned, to any person for influencing or attempting to influence an officer or employee of any agency, a member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with the awarding of any Federal contract, the making of any Federal grant, the making of any Federal loan, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Federal contract, grant, loan, or cooperative agreement.

B. If any funds other than Federal appropriated funds have been paid or will be paid to any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with this Federal contract, grant, loan, or cooperative agreement, the undersigned shall complete and submit Standard Form-LLL, Disclosure Form to Report Lobbying in accordance with its instructions.

C. The undersigned shall require that the language of this certification be included in the award documents for all sub-awards at all tiers (including subcontracts, sub-grants, and contracts under grants, loans and cooperative agreements) and that all sub-recipients shall certify and disclose accordingly.

This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into and is a prerequisite for making or entering into this transaction imposed by 31 U.S.C. 1352. Any person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure.

EXHIBIT B

Agreement Template Attached Separately – Please download document on the OSP website:

https://osp.admin.mn.gov/GS-auto labeled as Addendum 2.

EXHIBIT C

CERTIFICATION REGARDING LOBBYING

For State of Minnesota Contracts and Grants over $100,000

The undersigned certifies, to the best of his or her knowledge and belief that:

(1) No Federal appropriated funds have been paid or will be paid, by or on behalf of the undersigned, to any person for influencing or attempting to influence an officer or employee of any agency, a member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with the awarding of any Federal contract, the making of any Federal grant, the making of any Federal loan, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Federal contract, grant, loan, or cooperative agreement.

(2) If any funds other than Federal appropriated funds have been paid or will be paid to any person for influencing or attempting to influence an officer or employee of any agency, A Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with this Federal contract, grant, loan, or cooperative agreement, the undersigned shall complete and submit Standard Form-LLL, Disclosure Form to Report Lobbying in accordance with its instructions.

(3) The undersigned shall require that the language of this certification be included in the award documents for all subawards at all tiers (including subcontracts, subgrants, and contracts under grants, loans and cooperative agreements) and that all subrecipients shall certify and disclose accordingly.

This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into. Submission of this certification is a prerequisite for making or entering into this transaction imposed by 31 U.S.C. 1352. Any person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure.

Organization Name

Name and Title of Official Signing for Organization

By:_______________________________________

Signature of Official

Date

Workforce and Equal Pay Declarations Page Rev. 11/7/2022

Workforce and Equal Pay Declaration Page

This form is required for all businesses executing government contracts under the following:

Select one:

☐ Businesses executing a contract with State or Metropolitan agencies in excess of $100,000 (Workforce

Certificate) and if applicable $500,000 (Equal Pay Certificate)

☐ Businesses executing a contract with University of Minnesota for general obligation bond funded capital projects in excess of $100,000 (Workforce Certificate) and if applicable $500,000 (Equal Pay Certificate)

☐ Businesses executing a contract with Political Subdivisions for general obligation bond funded capital projects in excess of $250,000 (Workforce Certificate) and if applicable $1,000,000 (Equal Pay Certificate)

Select all that apply:

We are a Certificate holder:

☐ Workforce Certificate under the name: _________________________________________________________

☐ Equal Pay Certificate under the name: __________________________________________________________

We are applying/have applied for the following certificate(s):

☐ Workforce Certificate Application date (MM/DD/YYYY): ____________________

☐ Equal Pay Certificate Application date (MM/DD/YYYY): ____________________

We have not applied for one or both certificates:

☐ Our Company does not yet have a Workforce Certificate or Equal Pay Certificate. We acknowledge that a

Workforce and, if applicable, Equal Pay Certificate, or approved exemption by MDHR is required before a contract can be executed.

We are Exempt:

☐ We attest to MDHR that we have not employed 40 or more employees on a single day during the prior 12 months in Minnesota or the state in where we have our primary place of business. MDHR may request the names of our employees during the previous 12 months, the date of separation, if applicable, and the current employment status and count.

Business Information

Vendor/Supplier ID Business Name Name of Contracting Agency

Authorized Signatory Name Title Date

Signature Email Phone

For assistance with this form, email the Minnesota Department of Human Rights Compliance.MDHR@state.mn.us

Administration/MMCAP Infuse

(If applicable)

Not applicable - MMCAP Infuse WESA exemption memo dated Dec, 17, 2018

Not applicable - MMCAP Infuse WESA exemption memo dated Dec, 17, 2018

EXHIBIT D

https://mn.gov/mdhr/certificates/workforce-certificate/ https://mn.gov/mdhr/certificates/workforce-certificate/ https://mn.gov/mdhr/certificates/equalpay/ https://mn.gov/mdhr/certificates/workforce-certificate/ https://mn.gov/mdhr/certificates/equalpay/ https://mn.gov/mdhr/certificates/workforce-certificate/ https://mn.gov/mdhr/certificates/equalpay/ NXiong1 Highlight

EXHIBIT E

STATE OF MINNESOTA

VETERAN-OWNED PREFERENCE FORM

Unless a greater preference is applicable and allowed by law, in accordance with Minn. Stat. §16C.16, subd. 6a, the Commissioner of Administration will award up to a 12% preference on state procurement to certified small businesses that are majority owned and operated by veterans.

Veteran-Owned Preference Requirements - See Minn. Stat. § 16C.19(d):

1) The business has been certified by the Office of Equity in Procurement (OEP) as being a veteran-owned or service-disabled veteran-owned small business.

or

2) The principal place of business is in Minnesota AND the US Small Business Administration verifies the business as being a veteran-owned or service-disabled veteran-owned small business under Public Law 109- 461 and Code of Federal Regulations, title 13, part 128.

Statutory requirements and appropriate documentation must be met by the solicitation response due date and time to be awarded the veteran-owned preference. For Bids, the preference applies only to the first $2,000,000.

Claim the Preference

By signing below I confirm that:

My company is claiming the veteran-owned preference afforded by Minn. Stat. § 16C.16, subd. 6a. By making this claim, I verify that:

• The business has been certified by the Office of Equity in Procurement (OEP) as being a veteran-owned or service-disabled veteran-owned small business.

or

• My company’s principal place of business is in Minnesota and the US Small Business Administration verifies my company as being a veteran-owned or service-disabled veteran-owned small business.

Name of Company: _____________________________ Date: ________________________________

Authorized Signature: _____________________________ Telephone: ________________________________

Printed Name: _____________________________ Title: ______________________________________

Sign and return this form with your solicitation response to claim the veteran-owned preference.

EXHIBIT F

MMCAP Infuse Contracted Suppliers

Indicate the vendors Responder has current agreements and chargeback systems in place with. Respond directly into the table below and submit a completed Exhibit E with your response.

Number of NDCs on MMCAP Infuse contracts, currently

Currently stock and distribute?

Current chargeback system in place?

MMCAP Infuse-contracted vaccine and related product suppliers

Vaccine NDCs

(flu + non-flu)

Vaccine-related product NDCs

Yes No Yes No

AstraZeneca Pharmaceuticals LP 1

Bavarian Nordic, Inc. 3

Dynavax Technologies Corp. 1

Grifols USA, LLC. 1 69

GSK (GlaxoSmithKline), LLC. 20 + 2

Kedrion Biopharma Inc.

Merck Sharp & Dohme (vaccine division) 21

Par Pharmaceuticals 2

Pfizer Inc. 16

Sanofi Pasteur Inc. 19 + 8 2

Sanofi Pasteur Inc (Vaxelis) 2

Seqirus USA Inc. 5

Moderna US, Inc. 4

Novavax, Inc. 2

VBI Vaccines (Delaware) Inc 1

MMCAP Infuse -contracted service providers that may interact with resulting contracted Responders

Able to integrate with the following Vendors and systems?

Yes

No

Inmar/ RxTransparent for DSCSA Compliance Services

Inmar Rx for Pharmaceutical Returned…